Clinical Trials for MBX Biosciences

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: MBX Biosciences

Clinical Trials (5)

NCT07142707
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
PHASE1Recruiting
64 participants
Started: Sep 3, 2025 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT07029412
Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
PHASE2Recruiting
10 participants
Started: Aug 26, 2025 · Completed: Jan 26, 2026
1 condition1 sponsor4 locations
NCT06531941
Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
PHASE2Recruiting
48 participants
Started: Oct 31, 2024 · Completed: May 27, 2027
1 condition1 sponsor22 locations
NCT06465108
Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism
PHASE2Active, not recruiting
64 participants
Started: Aug 8, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor29 locations
NCT06496217
Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function
PHASE1Recruiting
32 participants
Started: May 24, 2024 · Completed: Oct 12, 2024
1 condition1 sponsor3 locations